Study of NGM120 in Subjects With Advanced Solid Tumors and Pancreatic Cancer Using Combination Therapy
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Bladder Cancer
- Colorectal Cancer
- Esophageal Cancer
- Gastric Cancer
- Head & Neck Squamous Cell Carcinoma
- Melanoma
- Metastatic Castration Resistant Prostate Cancer
- Non -Small Cell Lung Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: RandomizedIntervention Model: Sequential AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04068896
- Collaborators
- Not Provided
- Investigators
- Study Director: NGM Study Director NGM Biopharmaceuticals, Inc
Get Well Soon